ArticleMolecular medicine reports2021

Development and characterization of TrMab‑6, a novel anti‑TROP2 monoclonal antibody for antigen detection in breast cancer.

Yusuke Sayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.